Takeda Pharmaceutical Half-year Profit, Revenue Improve

Takeda Pharmaceutical Company Limited (TKPHF.PK,TAK) on Thursday said its Reported operating profit increased 60.5% to 346.0 billion yen during first half of the year.

Core earnings for the first half declined 2.8% to 335.9 billion Yen and core EPS decreased 3.3% to 214 Yen per share.

Reported net profit also showed a rise of more than 100% in the first half to 183.6 billion Yen or 117 Yen per share

However, the company said its core operating profit for the current period decreased 4.3% due to divestitures and increased R&D investment.

Reported revenue for the the six-month period increased 12.8% year-over-year to 1,794.4 billion, helped by sales growth in 14 global brands.

Core revenue for the period jumped 4.4% to 1,661.4 billion.

Looking forward to the full year, Takeda expects revenue to be 3,370 billion Yen. Reported EPS is expected at 117 Yen, and Core EPS at 394 Yen for the period.

The company also has set its annual dividend at 180 Yen per share.

Further, the company announced a share buyback program of up to 100 billion Yen.

"Takeda's strong commercial portfolio and R&D pipeline are diversified across four core therapeutic areas and represent innovative and potentially transformative benefits for patients. Altogether, we believe that the combination of these growth drivers will continue to propel our business forward and help to ensure our future growth is resilient, for not just the next quarter but the next decade," commented Christophe Weber, Chief Executive Officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Inditex SA were gaining around 6 percent in the morning trading in Spain after the clothing firm that owns Zara reported Wednesday significant growth in its first-quarter profit on higher revenues as well as the absence of a prior year provision. Regarding the second quarter to date, the company said its store and online sales in constant currency between May 1 and June 4 increased 16.. The U.S. Consumer Product Safety Commission or CPSC, along with Golden, Colorado-based Boppy Co., urged consumers to stop using recalled Boppy Newborn Loungers, following reports of more infant deaths. They also asked online marketplaces to stop selling the recalled product. The company in September 2021 had recalled over 3.3 million infant lounging pillows after it was connected with deaths of 8 Apple has unveiled a bunch of new products for its customers including its first spatial computer Vision Pro Headset. The tech major has also introduced iOS 17, 15-inch MacBook Air, iPadOS 17, TvOS 17 For Apple TV, WatchOS 10 For Apple Watch, New Mac Studio, Mac Pro, and M2 Ultra, among others. The Apple Vision Pro features visionOS, the world's first spatial operating system.
Follow RTT